Clinical trials: Survival Rate
Osteosarcoma
Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival
The purpose of this work is to carry out an exhaustive analysis of the characteristics of osteosarcoma in patients with an age equal to or greater than 40 years, in the Hospital de la Santa Creu and Sant Pau in Barcelona, during…
- Trial name
- NCT03911245
- Testing
- Retrospective study. Analyze of data in medical records
- Where
- Spain
- Volunteers
- 195 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Pink Esthetic Score, Implant Survival Rate
Factors Affecting Immediate Anterior Implants Esthetics.
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla.
- Conditions
- Pink Esthetic Score, Implant Survival Rate, Immediate Implant Placement
- Trial name
- NCT07539168
- Volunteers
- 500 people
- Sponsor
- International Dental Contiuing Education
Amyotrophic Lateral Sclerosis
Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
The primary objective of the trial is to investigate the survival time (the time from randomization until death or end of the trial) compared between control group and experimental group.
- Trial name
- NCT01879241
- Testing
- Rasagiline
- Where
- 15 sites in Germany
- Volunteers
- 252 people
- Sponsor
- University of Ulm
Tooth Fracture
Survival Rate of Adhesively Luted Veneers
The aims of this clinical study are: To evaluate the clinical performance between indirect composite and ceramic laminate veneers: Main interests are: colour stability of the restoration (digital measurement in follow up) failure…
- Trial name
- facings (NCT03145597)
- Testing
- Laminate veneer of composite, Laminate veneer of ceramic
- Where
- Netherlands
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- University Medical Center Groningen
Sarcoma,Soft Tissue, Nasal Cavity Cancer
Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus
Soft tissue sarcoma (STS) refers to a group of malignant tumors derived from non-epithelial extraosseous tissues, mainly from the mesoderm, partly from the neuroectoderm, including muscle, fat, fibrous tissue, blood vessels and…
- Conditions
- Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer, Surgery
- Trial name
- NCT05614375
- Testing
- endoscopic surgery
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Eye & ENT Hospital of Fudan University
Dental Caries
Survival Rate and Cost-effectiveness of Conventional vs ART Restorations in a School Setting
This study will investigate the performance and cost-effectiveness of glass-ionomer restorations placed in school children in an outreach setting in rural areas in South Africa over a 2-year period, when placed using either ART…
- Trial name
- NCT05766696
- Testing
- Atraumatic Restorative Treatment (ART), Conventional Cavity Preparation
- Where
- South Africa
- Volunteers
- 200 people
- Sponsor
- DMG Dental Material Gesellschaft mbH
Orthodontic Retention
Survival Rate of Two Types of Multistranded Fixed Retainers
1. Why is this study being done? After orthodontic treatment (such as braces), teeth can move back toward their original positions. To prevent this, orthodontists use retainers during the retention phase of treatment.
- Trial name
- Surv_Retain (NCT07476950)
- Testing
- Placement of round twisted retainer wire, Placement of rectangular braided retainer wire
- Volunteers
- 133 people
- Sponsor
- Piotr Fudalej
Esophagus Cancer
Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer
The purpose of this study is to evaluate the efficacy and safety of Qizhu Yuling prescription for postoperative esophagus cancer.
- Trial name
- NCT05626309
- Testing
- Qizhu Yuling Prescription
- Where
- 3 sites in China
- Volunteers
- 310 people
- Sponsor
- Jie Li
Progress-free Survival, Overall Response Rate
Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE
Breast cancer is the most common malignant disease and the most frequent causes of cancer mortality in females worldwide. The situation is same as the world in China.
- Conditions
- Progress-free Survival, Overall Response Rate, Adverse Events
- Trial name
- HOPES (NCT01291667)
- Volunteers
- 330 people
- Sponsor
- Shanghai CP Guojian Pharmaceutical Co., Ltd.
Gastric Cancer, Survival Rate
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
The study focuses on patients with locally advanced gastric adenocarcinoma (cT3N+M0 and cT4aN+/-M0), assessing the feasibility, surgical safety, and oncological benefit of prophylactic HIPEC treatment following laparoscopic D2…
- Trial name
- NCT06525714
- Testing
- cisplatin oxaliplatin tegafur
- Volunteers
- 302 people, healthy volunteers welcome
- Sponsor
- The First Hospital of Jilin University
Knee Replacement
Results of a Mobile Unicompartimental Knee Prosthesis
The unicompartmental knee prosthesis has become a routine procedure. Survival rate of over 90% after 10 years are generally reported.
- Trial name
- NCT03130309
- Where
- France
- Volunteers
- 70 people
- Sponsor
- University Hospital, Strasbourg, France
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
The purpose of the study is to evaluate the safety and tolerability of pepinemab in combination with pembrolizumab as first-line treatment and determine a recommended Phase 2 dose (RP2D) in patients with recurrent or metastatic…
- Trial name
- KEYNOTE-B84 (NCT04815720)
- Testing
- pepinemab + pembrolizumab
- Where
- 15 sites in United States
- Volunteers
- 49 people
- Sponsor
- Vaccinex Inc.
Kidney Transplant Failure, Kidney Function Issue
Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease After Kidney Transplantation
The gold standard for characterizing chronic kidney disease (CKD) is the glomerular filtration rate (GFR), which is commonly estimated in both native and transplanted kidneys for patient monitoring and therapeutic management and…
- Trial name
- TRAJAKT (NCT04226859)
- Testing
- No intervention
- Where
- 15 sites in United States, Belgium and 2 more
- Volunteers
- 14,000 people
- Sponsor
- Paris Translational Research Center for Organ Transplantation
Alveolar Bone Loss, Bone Resorption
Outcome of Implant-supported Overdentures
The aim of this pilot study was to assess survival rates and peri-implant bone loss of two narrow-diameter titanium-zirconium implants supporting maxillary and mandibular overdentures during an observation time of 3 years.
- Conditions
- Alveolar Bone Loss, Bone Resorption, Dental Implants, Edentulous Maxilla
- Trial name
- NCT03777748
- Testing
- dental implants and stud attachments
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- RWTH Aachen University
Dental Implants
Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System
Global D has developed an zygomatic implant prosthetic system (ZygoFixU range): zygomatic implants, prosthetic parts and associated instruments.
- Trial name
- NCT06960460
- Testing
- Dental implant surgery with ZygoFixU implants
- Where
- 3 sites in France, Italy
- Volunteers
- 99 people
- Sponsor
- Global D
Neoplasm Metastasis, Spinal Cord Compression
Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate
Patients with metastatic spinal cord compression (MSCC) are treated with different options according to the life expectancy. Survival and surgical outcome can be influenced by surgical timing in MSCC patients treated with…
- Trial name
- NCT02934594
- Testing
- Palliative Decompression
- Volunteers
- 500 people
- Sponsor
- National Taiwan University Hospital
Gastric Cancer
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer
The purpose of this study is to evaluate the efficacy and tolerability of the ECF regimen (epirubicin, cisplatin and FU) combined with endostar-- a inhibitor of angiogenesis, in patients with advanced or metastatic gastric cancer…
- Trial name
- NCT00595972
- Testing
- ECF-endostar
- Where
- China
- Volunteers
- 25 people
- Sponsor
- Fudan University
Surgical Operation With Implant of Artificial Internal Device
A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice
Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement
- Trial name
- BLX_NIS (NCT03613077)
- Testing
- surgical placement of an endosteal implant
- Where
- Germany
- Volunteers
- 153 people
- Sponsor
- Institut Straumann AG
Progression Free Survival
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
Treatment options for patients with colorectal cancer (CRC) have increased in the last years. However, there are no validated prospective molecular markers in CRC to select which agents are better to treat any individual case.
- Trial name
- TT (NCT01453257)
- Testing
- Tailored Chemotherapy
- Where
- Spain
- Volunteers
- 72 people
- Sponsor
- Grupo Hospital de Madrid
Histologic Response (Tumor Necrosis Rate), Objective Response Rate for Neoadjuvant Chemotherapy, ORR
Epigenetic Biomarker for Osteosarcoma
hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively label 5hmC with a biotin via an azide-modified glucose for pull-down…
- Conditions
- Histologic Response (Tumor Necrosis Rate), Objective Response Rate for Neoadjuvant Chemotherapy, ORR, Progression-free Survival, PFS, Overall Survival, OS
- Trial name
- NCT03336554
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University People's Hospital